Hassounah, Nadia B.
Malladi, Venkat S.
Huang, Yi
Freeman, Samuel S.
Beauchamp, Ellen M.
Koyama, Shohei
Souders, Nicholas
Martin, Sunil
Dranoff, Glenn
Wong, Kwok-Kin
Pedamallu, Chandra S.
Hammerman, Peter S.
Akbay, Esra A. http://orcid.org/0000-0002-4149-2529
Funding for this research was provided by:
National Cancer Institute (CA205150, CA196932, K08 CA163677, 5P50CA070907)
Starr Consortium for Cancer Research
International Association for the Study of Lung Cancer (Young Investigator Award)
Cancer Prevention and Research Institute of Texas (RR160080)
Article History
Received: 25 May 2018
Accepted: 6 December 2018
First Online: 18 December 2018
Compliance with ethical standards
:
: The authors have no relevant conflicts to disclose.
: Informed consent was obtained from blood donors from the Brigham and Women’s Blood Bank under the approved IRB protocol 02-180.
: HEK293T cells were purchased from ATCC, and RKO, CAL62, and RERF-LC-Ad1 cells were obtained from the CCLE [CitationRef removed] through the Broad Institute of Massachusetts Institute of Technology and Harvard. All cells were used within 6 months of initial passage and not further authenticated.